Thyssenkrupp's October Spin-Off Draws Near as Hydrogen Setback Tests the Conglomerate's Two-Track Revival

Thyssenkrupp's TK Accelis spin-off set for late October listing; Nucera slashes outlook, while parent raises profit floor.

The restructuring machinery at Thyssenkrupp is shifting from shareholder approval to hard deadlines. With the extraordinary general meeting in early August delivering a 99.99 percent mandate for the separation of the tk accelis division, management has now pencilled in the final registration with the commercial register for late October, with the listing of TK Accelis Group AG & Co. KGaA to follow almost immediately. For holders of the German industrial conglomerate's shares, the long-promised breakup is no longer a concept but a calendar event.

The mechanics of the spin-off have been settled: existing Thyssenkrupp shareholders will receive 49 percent of tk accelis, with one Kommanditaktie issued for every 20 shares of the TK Accelis Group held. The corporate reorganisation also carries a structural consequence for the parent, which will be recast as a financial holding company under the amended articles of association.

Yet the run-up to the October milestone is unfolding against a conspicuously uneven operational backdrop. The hydrogen-focused subsidiary Thyssenkrupp Nucera has pulled the plug on its in-house mass production of SOEC stacks, the solid-oxide electrolysis technology that had been positioned as a growth pillar. The retreat carries a one-off charge of roughly €30 million in the current quarter, stemming from writedowns on a pilot plant and capitalised development costs. Nucera has responded by narrowing its full-year EBIT guidance to a loss of between €105 million and €75 million, a marked deterioration from the previous range of minus €80 million to minus €30 million.

Revenue expectations have been trimmed in tandem. The subsidiary now guides for sales of €450 million to €500 million, down from an earlier ceiling of €550 million, with the green hydrogen segment absorbing the brunt of the cut — the unit's revenue outlook has been lowered to €100 million to €130 million from a prior maximum of €170 million. The chlor-alkali business, by contrast, has been left untouched by the revision.

The timing of the Nucera setback is awkward, arriving as it does in the same week that Thyssenkrupp lifted the floor on its own full-year profit forecast. On 13 August, management raised the lower bound of its adjusted EBIT guidance to €600 million from €500 million, keeping the ceiling at €900 million, while also narrowing the net income range. The upgrade reflects momentum in the core operations, not least at Thyssenkrupp Marine Systems, which on 12 August raised its own outlook after nine months of the fiscal year, citing considerably stronger growth than previously assumed. The warship builder now ranks alongside the steel business as one of the group's principal growth engines.

The contrast between the two divisions underscores the balancing act at the heart of the Thyssenkrupp story. The parent is approaching a strategic inflection point with the spin-off and its conversion into a holding structure, while its separately listed hydrogen affiliate wrestles with the cost of an abandoned technology bet. For shareholders of the parent, the Nucera issue remains a peripheral concern for now — the stake is a standalone listing — but it serves as a reminder that the group's growth fields carry very different levels of execution risk.

Nucera has at least offered a forward-looking sweetener: the strategic repositioning is expected to deliver positive effects of €10 million on EBIT and €20 million on cash flow in the 2026/27 fiscal year. That prospect, however, does little to offset the immediate drag on the subsidiary's current-year results.

The equity market, for its part, appears to be looking through the hydrogen turbulence. The Thyssenkrupp share closed Friday at €14.67, down 1.2 percent on the day, but the weekly performance tells a different story: a gain of 7.9 percent, extending a 30-day advance of 22 percent. Since the start of the year, the stock has appreciated by 57 percent, and with the 52-week high of €15.18 — set on 28 August — now just 3.4 percent away, the shares are trading within striking distance of their annual peak. The market capitalisation stands at €9.18 billion.

Technical indicators suggest the rally may be running hot: the relative strength index sits at 68.6, edging toward overbought territory after such a sustained run. That cautionary signal, though, has yet to dent the prevailing optimism around the conglomerate's transformation.

Investors now have a clear sequence of events to track. Late September brings a capital markets day for the steel division, Thyssenkrupp Steel Europe, where management is expected to flesh out the strategic direction of that business. The October listing of TK Accelis Group will then test how the market prices the newly created structure, with the full third-quarter results due to underpin the upgraded guidance. The immediate question is whether the spin-off can deliver on its promise of a cleaner, more transparent Thyssenkrupp — and whether the hydrogen stumble proves to be a contained misstep or a harbinger of further write-offs in the group's greener ambitions.